Navigation Links
The New MACSQuant(TM) Analyzer Combines Cell Enrichment and Flow Cytometry
Date:1/16/2009

BERGISCH GLADBACH, Germany, January 16 /PRNewswire/ -- Miltenyi Biotec announces the worldwide release of the MACSQuant(TM) Analyzer, a novel and compact flow cytometer for multiparameter cell analysis. With this instrument launch Miltenyi Biotec broadens the product portfolio of the cell analysis business section and offers customers a milestone flow cytometer with novel features. "Whether working with one or 96 samples, the MACSQuant Analyzer can efficiently perform sample labeling and sensitive 7-color flow analysis in a fully automated fashion", states Product Manager Dr. Craig Fuller. "Rare cell populations can be reliably and reproducibly analyzed by enrichment of target cells using the integrated MACS(R) Cell Enrichment Unit and MACS(R) Technology", he continues. "With a wide range of reagents to choose from, the possibilities for the analysis of rare cells are extensive." The MACSQuant Analyzer boasts many additional features, such as absolute cell counting, remote instrument control, and automated instrument housekeeping procedures. All of this is touchscreen-operated using an intuitive, user-friendly program: the MACSQuantify(TM) Software. These outstanding features create an ideal instrument for core facilities, departmental collaborations, and individual laboratories. More details are provided at http://www.macsquant.com.

About Miltenyi Biotec

The company is one of the largest and most successful biotechnology companies in Germany. More than 1,100 employees develop, produce and sell products for biomedical research and clinical applications. The renowned MACS Technology for magnetic separation of cells has become a standard technology in research laboratories worldwide.

    Contact

    Prof. Dr. Uwe Heinlein, Corporate Communications, Miltenyi Biotec GmbH
    Friedrich-Ebert-Str. 68, 51429 Bergisch Gladbach, Germany
    Phone +49-2204-8306-6590, e-mail uweh@miltenyibiotec.de
   http://www.miltenyibiotec.com




'/>"/>
SOURCE Miltenyi Biotech GmbH
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
2. febit to Introduce Geniom RT Analyzer(R) to U.S. Market at RNAi World Congress
3. Instrumentation Laboratory Ships 1000th GEM Premier 4000 Analyzer to Scripps Health
4. New CO-oximetry Module for the ABL80 FLEX Blood Gas Analyzer
5. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
6. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
7. Elseviers Engineering Village Search Platform Combines the American Geological Institutes Georef Database With Google Maps
8. BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology
9. Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies
10. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
11. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a major ... and GSK to generate genetic sequence data from the 500,000 ... enable researchers to gain valuable insights to support advances in ... serious and life threatening diseases. ... Genetic evidence has revolutionized scientific ...
(Date:3/22/2017)... JERUSALEM , March 22, 2017 ... ( www.oramed.com ), ... of oral drug delivery systems, announced today that ... Officer, will deliver a presentation titled, "Oral Insulin ... upcoming Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics ...
Breaking Biology Technology:
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
Breaking Biology News(10 mins):